<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8728246</article-id>
    <article-id pub-id-type="pmid">34850110</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkab1128</article-id>
    <article-id pub-id-type="publisher-id">gkab1128</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ConsensusPathDB 2022: molecular interactions update as a resource for network biology</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Kamburov</surname>
          <given-names>Atanas</given-names>
        </name>
        <aff><institution>R&amp;D Digital Technologies Department, Bayer AG</institution>, <addr-line>Berlin</addr-line> <addr-line>13353</addr-line>, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9335-1760</contrib-id>
        <name>
          <surname>Herwig</surname>
          <given-names>Ralf</given-names>
        </name>
        <!--herwig@molgen.mpg.de-->
        <aff><institution>Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics</institution>, <addr-line>Berlin</addr-line> <addr-line>14195</addr-line>, <country country="DE">Germany</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +49 30 84131587; Fax: +49 30 84131152; Email: <email>herwig@molgen.mpg.de</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>07</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-11-25">
      <day>25</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>25</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <volume>50</volume>
    <issue>D1</issue>
    <fpage>D587</fpage>
    <lpage>D595</lpage>
    <history>
      <date date-type="accepted">
        <day>04</day>
        <month>11</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>21</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>9</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkab1128.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Molecular interactions are key drivers of biological function. Providing interaction resources to the research community is important since they allow functional interpretation and network-based analysis of molecular data. ConsensusPathDB (<ext-link xlink:href="http://consensuspathdb.org" ext-link-type="uri">http://consensuspathdb.org</ext-link>) is a meta-database combining interactions of diverse types from 31 public resources for humans, 16 for mice and 14 for yeasts. Using ConsensusPathDB, researchers commonly evaluate lists of genes, proteins and metabolites against sets of molecular interactions defined by pathways, Gene Ontology and network neighborhoods and retrieve complex molecular neighborhoods formed by heterogeneous interaction types. Furthermore, the integrated protein–protein interaction network is used as a basis for propagation methods. Here, we present the 2022 update of ConsensusPathDB, highlighting content growth, additional functionality and improved database stability. For example, the number of human molecular interactions increased to 859 848 connecting 200 499 unique physical entities such as genes/proteins, metabolites and drugs. Furthermore, we integrated regulatory datasets in the form of transcription factor–, microRNA– and enhancer–gene target interactions, thus providing novel functionality in the context of overrepresentation and enrichment analyses. We specifically emphasize the use of the integrated protein–protein interaction network as a scaffold for network inferences, present topological characteristics of the network and discuss strengths and shortcomings of such approaches.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Federal Ministry of Education and Research</institution>
            <institution-id institution-id-type="DOI">10.13039/501100002347</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>161L0242A</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>European Commission Horizon 2020 Framework Programme</institution>
          </institution-wrap>
        </funding-source>
        <award-id>811034</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Max Planck Society</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004189</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Modern biomedical experiments, for example the generation of cell atlases (<xref rid="B1" ref-type="bibr">1</xref>) or patient-derived disease-associated data (<xref rid="B2" ref-type="bibr">2</xref>), rely on high-throughput experiments such as sequencing, proteomics or genome-wide methylation experiments and agglomerate heterogeneous information from these diverse experiments. An important step in these workflows is the integration and interpretation of the data in the context of biological pathways and networks.</p>
    <p>Biological networks typically consist of molecular interactions that have been experimentally measured by proteomics or genetic technologies, reported in the literature and assembled in interaction databases (<xref rid="B3" ref-type="bibr">3</xref>). However, such databases are often complementary in terms of content and tend to focus on one or a few types of interactions, while in biological processes all the different interaction types coexist in the cell. In order to obtain a global interaction map that reflects cell biology as comprehensively as possible, subject to the currently available interaction knowledge, many available interaction resources have to be used in parallel. Furthermore, it has been shown that the choice of a pathway database for analyzing a given dataset impacts results of gene enrichment analyses (<xref rid="B4" ref-type="bibr">4</xref>), which necessitates integration across such resources.</p>
    <p>To this end, we have developed and maintained (since 2009) the ConsensusPathDB database that integrates different types of interactions from numerous resources into a seamless global network (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>). In this network, physical entities (genes, proteins, protein complexes, metabolites, drugs, etc.) from different interaction sources are matched based on their accession numbers and interactions are matched based on the physical entities involved to reduce data redundancy. In ConsensusPathDB, we have agglomerated the content of 31 major public repositories on human molecular interactions of heterogeneous types as well as biochemical pathways resulting in one of the largest interactome maps available. Furthermore, separate instances of the database integrate the content of 16 mouse and 14 yeast interaction repositories, respectively. The web interface enables the research community to search and visualize complex subnetworks as well as to carry out overrepresentation/enrichment analysis and network analysis of lists of proteins, genes and metabolites (e.g. from large-scale experiments) in order to interpret experimental data. The integrated resources can be downloaded and used for network analysis, e.g. for network propagation-based methods. For example, the integrated protein–protein interaction (PPI) network of ConsensusPathDB has been recently benchmarked as one of the top-performing networks for disease gene identification among 21 comparable resources (<xref rid="B7" ref-type="bibr">7</xref>) and has been used for identifying network modules for monitoring drug actions across heterogeneous experiments (<xref rid="B8" ref-type="bibr">8</xref>).</p>
    <p>In this 2022 update of ConsensusPathDB, we describe the novel content and functionality recently added to the database and the web interface, respectively. Notably, additional regulatory gene sets have been added to the overrepresentation and enrichment functionality comprising microRNA–, transcription factor– and enhancer–gene target sets, adding to the previously available options of using curated pathways, Gene Ontology (<xref rid="B9" ref-type="bibr">9</xref>) categories, network neighborhoods and protein complexes. Furthermore, we describe and characterize the new integrated PPI network that now comprises 522 618 human binary, physical interactions as a scaffold for network propagation analyses. ConsensusPathDB is freely accessible under <ext-link xlink:href="http://consensuspathdb.org" ext-link-type="uri">http://consensuspathdb.org</ext-link>.</p>
  </sec>
  <sec id="SEC2">
    <title>ConsensusPathDB CONTENT UPDATE 2022</title>
    <sec id="SEC2-1">
      <title>Source databases and types of molecular interactions</title>
      <p>Since our last report on ConsensusPathDB (<xref rid="B5" ref-type="bibr">5</xref>), the database has grown significantly in content (see Table <xref rid="tbl1" ref-type="table">1</xref> for human resources and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref> for mouse and yeast resources). While the number of interaction source databases integrated in ConsensusPathDB stayed fairly constant (with the exception of DrugBank dropping out due to new access restrictions), its overall content increased significantly. Since the last report (<xref rid="B5" ref-type="bibr">5</xref>), the number of unique interactions stored in ConsensusPathDB has grown from 215 541 (version 25) to 859 848 human interactions in the current version 35 (+299%) mainly because the content of the included resources has grown. For human interactions, the integrated resources comprise 31 databases: BIND (<xref rid="B10" ref-type="bibr">10</xref>), BioCarta (<xref rid="B11" ref-type="bibr">11</xref>), Biogrid (<xref rid="B12" ref-type="bibr">12</xref>), CORUM (<xref rid="B13" ref-type="bibr">13</xref>), ChEMBL (<xref rid="B14" ref-type="bibr">14</xref>), DIP (<xref rid="B15" ref-type="bibr">15</xref>), EHMN (<xref rid="B16" ref-type="bibr">16</xref>), HPRD (<xref rid="B17" ref-type="bibr">17</xref>), HumanCyc (<xref rid="B18" ref-type="bibr">18</xref>), INOH (<xref rid="B19" ref-type="bibr">19</xref>), InnateDB (<xref rid="B20" ref-type="bibr">20</xref>), IntAct (<xref rid="B21" ref-type="bibr">21</xref>), KEGG (<xref rid="B22" ref-type="bibr">22</xref>), MINT (<xref rid="B23" ref-type="bibr">23</xref>), MIPS-MPPI (<xref rid="B24" ref-type="bibr">24</xref>), MatrixDB (<xref rid="B25" ref-type="bibr">25</xref>), NetPath (<xref rid="B26" ref-type="bibr">26</xref>), PDB (<xref rid="B27" ref-type="bibr">27</xref>), PDZBase (<xref rid="B28" ref-type="bibr">28</xref>), PID (<xref rid="B29" ref-type="bibr">29</xref>), PIGDB (<xref rid="B30" ref-type="bibr">30</xref>), PINdb (<xref rid="B31" ref-type="bibr">31</xref>), PharmGKB (<xref rid="B32" ref-type="bibr">32</xref>), PhosphoPOINT (<xref rid="B33" ref-type="bibr">33</xref>), PhosphoSitePlus (<xref rid="B34" ref-type="bibr">34</xref>), Reactome (<xref rid="B35" ref-type="bibr">35</xref>), SMPDB (<xref rid="B36" ref-type="bibr">36</xref>), SignaLink (<xref rid="B37" ref-type="bibr">37</xref>), SPIKE (<xref rid="B38" ref-type="bibr">38</xref>), TTD (<xref rid="B39" ref-type="bibr">39</xref>) and WikiPathways (<xref rid="B40" ref-type="bibr">40</xref>).</p>
      <table-wrap position="float" id="tbl1">
        <label>Table 1.</label>
        <caption>
          <p>Growth figures describing the increase in content of human interactions with respect to the last database publication in 2013 (<xref rid="B5" ref-type="bibr">5</xref>)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th colspan="3" align="center" rowspan="1">Human</th>
            </tr>
            <tr>
              <th rowspan="1" colspan="1">Interaction type</th>
              <th rowspan="1" colspan="1">2013: version 25 (# interactions)</th>
              <th rowspan="1" colspan="1">2022: version 35 (# interactions)</th>
              <th rowspan="1" colspan="1">Content growth (# interactions)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Protein–protein</td>
              <td rowspan="1" colspan="1">155 855</td>
              <td rowspan="1" colspan="1">616 304</td>
              <td rowspan="1" colspan="1">460 449</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Signaling or metabolic</td>
              <td rowspan="1" colspan="1">20 682</td>
              <td rowspan="1" colspan="1">25 046</td>
              <td rowspan="1" colspan="1">4364</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Gene regulatory</td>
              <td rowspan="1" colspan="1">5658</td>
              <td rowspan="1" colspan="1">18 912</td>
              <td rowspan="1" colspan="1">13 254</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Genetic</td>
              <td rowspan="1" colspan="1">265</td>
              <td rowspan="1" colspan="1">7936</td>
              <td rowspan="1" colspan="1">7671</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Drug–target</td>
              <td rowspan="1" colspan="1">33 081</td>
              <td rowspan="1" colspan="1">191 650</td>
              <td rowspan="1" colspan="1">158 569</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Gene target sets</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>2013: version 25 (# sets)</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>2022: version 35 (# sets)</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Content growth (# sets)</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Pathways</td>
              <td rowspan="1" colspan="1">4601</td>
              <td rowspan="1" colspan="1">5578</td>
              <td rowspan="1" colspan="1">977</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Protein complex-derived sets</td>
              <td rowspan="1" colspan="1">39 685</td>
              <td rowspan="1" colspan="1">244 987</td>
              <td rowspan="1" colspan="1">205 302</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">miRNA–gene target</td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">5474</td>
              <td rowspan="1" colspan="1">5474</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Transcription factor–gene target</td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">800</td>
              <td rowspan="1" colspan="1">800</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Enhancer–gene target sets<xref rid="T1TFN1" ref-type="table-fn"><sup>a</sup></xref></td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">217 790</td>
              <td rowspan="1" colspan="1">217 790</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="T1TFN1">
            <label>
              <sup>a</sup>
            </label>
            <p>It should be noted that enhancer–gene target sets are highly redundant across different cell types.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>A major motivation for providing a meta-resource for molecular interactions is the complementarity of the different source databases. Analysis of the total number of source databases per interaction in ConsensusPathDB shows that the respective distribution is right-skewed, with most of the interactions (83%) originating from a single source database (Figure <xref rid="F1" ref-type="fig">1A</xref>). These results show that currently available databases are highly complementary and, importantly, that the integrated interaction map present in ConsensusPathDB has not saturated yet. The proportion of ‘unique’ interactions has even slightly increased compared to the 2013 version 25 of ConsensusPathDB where we observed 75% single-source interactions. This underlines the continued need for integration of interaction data in order to generate more complete interactomes. Most of the integrated interactions are protein interactions (72%) in the form of protein–protein binary interactions and protein complexes followed by drug–target interactions (22%) and biochemical reactions (3%) covering metabolic and signaling processes.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>ConsensusPathDB content. (<bold>A</bold>) Number of interactions (<italic toggle="yes">Y</italic>-axis) shared by number of source databases (<italic toggle="yes">X</italic>-axis). The rightmost tail of the histogram is magnified. The colors within each bar represent the different interaction types. (<bold>B</bold>) Venn diagram of overlapping gene sets for the apoptosis pathway annotated by three prominent pathway databases: KEGG (pathway identifier: hsa04210), Reactome (R-HSA-109581) and WikiPathways (WP254). (<bold>C</bold>) Interaction display for the TOP1 (<italic toggle="yes">DNA topoisomerase I</italic>) gene. Binary interactions are scored for confidence and the confidence value is displayed by a traffic light symbol. Each interaction assigns a specific role to the molecule under study (e.g. ‘<italic toggle="yes">I</italic>’ interactor, ‘<italic toggle="yes">T</italic>’ target) and has an external link to the annotating source database. Interactions can be selected for further visualization. (<bold>D</bold>) Visualization of selected interactions of TOP1. Interactions are displayed with colored nodes indicating the interaction type and interacting molecules are displayed with colored squares indicating their type. Each connection represents a source database that has annotated the interaction. Clicking on each interaction (or molecule) displays further information about the interaction, the confidence score and supporting publications.</p>
        </caption>
        <graphic xlink:href="gkab1128fig1" position="float"/>
      </fig>
      <p>The individual databases have variable contribution to the overall content of ConsensusPathDB. The five largest resources are Biogrid (495 966 interactions), IntAct (162 374), ChEMBL (143 258), TTD (43 878) and HPRD (40 484). Also, the contribution to the novel interactions is largely driven by a few databases (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>), namely Biogrid (418 831 novel interactions; 53% of all novel interactions), IntAct (146 989; 19%), ChEMBL (143 258; 18%) and TTD (40 621; 5%), which account for 95% of all novel interactions.</p>
      <p>In addition to molecular interactions, ConsensusPathDB contains 5578 pre-annotated pathway gene sets from 12 resources (KEGG, Reactome, WikiPathways, BioCarta, EHMN, HumanCyc, INOH, NetPath, PID, PharmGKB, SMPDB and SignaLink) available for overrepresentation and enrichment analyses. Complementarity of the annotation is also observable in this pathway content. For example, the gene sets for apoptosis signaling—one of the best studied pathways that has high relevance for cancer—provided by three prominent pathway databases [KEGG (hsa04210), Reactome (R-HSA-109581) and WikiPathways (WP254)] differ significantly, with 74% of the genes being unique to one of the databases, whereas only 13% of the genes are common for all three gene sets (Figure <xref rid="F1" ref-type="fig">1B</xref>). This ‘annotation bias’ can interfere with gene set enrichment analyses (<xref rid="B4" ref-type="bibr">4</xref>) and justifies using a variety of resources in such analysis workflows rather than only a single one.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Integrative view on heterogeneous molecular interactions</title>
      <p>The user can explore all integrated interactions of a molecule of interest in ConsensusPathDB through the web interface in several steps. In the first step, the molecule of interest can be retrieved by typing an identifier or molecule name. It is recommended to use official symbols, or UniProt or Ensembl identifiers in case of genes or proteins and KEGG, ChEBI or PubChem identifiers in the case of metabolites or drugs, since these are the basic annotation types of ConsensusPathDB. The database returns all entries that match with the search term. After selecting an entry, all interactions are listed with the gene/protein/metabolite of interest (Figure <xref rid="F1" ref-type="fig">1C</xref>). In case of binary PPIs, a confidence value is provided as a ‘traffic light’ icon in order to help structuring and reviewing the output. In the third step, interactions can be selected and visualized, enabling integrated views across heterogeneous interaction types and interaction resources (Figure <xref rid="F1" ref-type="fig">1D</xref>).</p>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>ADDITION OF NOVEL REGULATORY GENE SETS</title>
    <sec id="SEC3-1">
      <title>Overrepresentation and enrichment analyses</title>
      <p>Among the most widely used features of ConsensusPathDB are to perform enrichment analyses of user-defined lists of genes/proteins and metabolites with respect to pre-annotated pathways, GO categories, protein complexes and network neighborhoods as defined by the integrated PPI network. Overrepresentation analysis requires a simple list of gene/protein, metabolite, or identifiers and is computed with Fisher’s exact test. Enrichment analysis requires in addition numerical data from two different states for comparison (e.g. disease versus healthy state) and is computed with Wilcoxon’s rank sum test (<xref rid="B41" ref-type="bibr">41</xref>).</p>
      <p>In this 2022 update, the basis for overrepresentation and enrichment analysis functionality has been extended to include regulatory gene sets in the form of microRNA–, transcription factor– and enhancer–gene target sets. As epigenetic studies and studies on post-transcriptional regulation have become frequent, we have thus addressed the need for analysis tools for such data based on gene sets defined by regulatory relationships in the current ConsensusPathDB version. Target gene sets were included from three different microRNA databases [TargetScan version 7.2 (<xref rid="B42" ref-type="bibr">42</xref>), miRTarBase version 8.0 (<xref rid="B43" ref-type="bibr">43</xref>) and miRDB version 6.0 (<xref rid="B44" ref-type="bibr">44</xref>)], one transcription factor–target interaction resource [TRRUST version 2 (<xref rid="B45" ref-type="bibr">45</xref>)] and one enhancer–target interaction resource [EnhancerAtlas version 2.0 (<xref rid="B46" ref-type="bibr">46</xref>)].</p>
    </sec>
    <sec id="SEC3-2">
      <title>Use case 1: exploring post-transcriptional regulation for cardiotoxicity</title>
      <p>Recently, we have analyzed the effects of four anticancer therapies (doxorubicin, epirubicin, idarubicin and daunorubicin) in a human 3D cardiac microtissue model and identified a network of 142 proteins (<xref rid="sup1" ref-type="supplementary-material">Supplementary Data S1</xref>) that revealed common dynamic changes as measured with transcriptomic and proteomic time course experiments (<xref rid="B8" ref-type="bibr">8</xref>). It is well known that anthracyclines induce cardiotoxicity in patients, so we explored the ConsensusPathDB for information on disease pathways and metabolic processes that might be altered after drug treatment. Pathway overrepresentation with the set of 142 genes reveals multiple pathways related to cardiac diseases (<xref rid="sup1" ref-type="supplementary-material">Supplementary Data S1</xref>) such as ‘diabetic cardiomyopathy’ (KEGG hsa05415, <italic toggle="yes">Q</italic> = 8.02e−08) and ‘striated muscle contraction’ (Reactome R-HSA-390522, <italic toggle="yes">Q</italic> = 172e−07), among others, as well as metabolic pathways related to ‘electron transport’ (Reactome R-HSA-611105, <italic toggle="yes">Q</italic> = 721e−07; WikiPathways WP111, <italic toggle="yes">Q</italic> = 168e−05) and the ‘TCA cycle’ (Reactome R-HSA-1428517, <italic toggle="yes">Q</italic> = 887e−14; KEGG hsa00020, <italic toggle="yes">Q</italic> = 154e−10; EHMN TCA cycle, <italic toggle="yes">Q</italic> = 802e−08; HumanCyc PWY66-398, <italic toggle="yes">Q</italic> = 106e−07; WikiPathways WP78, <italic toggle="yes">Q</italic> = 146e−06) that account for mitochondrial dysfunction and relevant cardiotoxicity response pathways (<xref rid="B47" ref-type="bibr">47</xref>).</p>
      <p>In addition to such pathway-based analyses, the ConsensusPathDB 2022 offers the analysis of microRNA–gene target sets. Overrepresentation analysis reveals 16 significantly enriched microRNA target sets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Data S1</xref>; <italic toggle="yes">Q</italic> &lt; 0.05). The top three candidates are those regulated by miR-615-3p, miR1-3p and miR92a-3p (<italic toggle="yes">Q</italic> = 0.00098) annotated from miRTarBase version 8.0. Literature evidence supports the role of these microRNAs for cardiac function and toxicity. For example, deletion of miR92a-3p has been reported to exert cardioprotective effects in mice (<xref rid="B48" ref-type="bibr">48</xref>). Most evidence has been reported for miR1-3p: in a recent study on human patients, it was found that different forms of cardiomyopathies had typical microRNA patterns and that miR1-3p was specific for hypertrophic cardiomyopathy where it was also correlating with clinical parameters such as left ventricular ejection function (<xref rid="B49" ref-type="bibr">49</xref>). More specifically, miR1-3p has been proposed as a biomarker for doxorubicin-induced cardiotoxicity after treatment of breast cancer patients, which accounts for the origin of the selected gene targets in the <italic toggle="yes">in vitro</italic> microtissue model (<xref rid="B50" ref-type="bibr">50</xref>). This use case exemplifies that the newly integrated gene sets can expand the knowledge from transcriptomics/proteomics-derived gene lists to post-transcriptional regulatory information.</p>
    </sec>
    <sec id="SEC3-3">
      <title>Use case 2: tissue-specific genes and transcription factors</title>
      <p>Tissue-specific processes are often regulated by specific transcription factors and through the specific connections between transcription factors and their gene targets (<xref rid="B51" ref-type="bibr">51</xref>). Thus, enrichment analysis of transcription factor–target sets evaluated against user gene lists can provide valuable insights into regulatory mechanisms. We exemplified this by downloading the 100 most highly expressed genes across 226 liver samples as provided by the GTEx Consortium (<xref rid="B52" ref-type="bibr">52</xref>). Overrepresentation analysis with ConsensusPathDB reveals nine transcription factors significantly enriched by the top liver-expressed genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Data S2</xref>; <italic toggle="yes">Q</italic> &lt; 0.05): <italic toggle="yes">NR2F1</italic>, <italic toggle="yes">HNF4A</italic>, <italic toggle="yes">CEBPB</italic>, <italic toggle="yes">NR2F6</italic>, <italic toggle="yes">STAT3</italic>, <italic toggle="yes">HNF1A</italic>, <italic toggle="yes">CEBPA</italic>, <italic toggle="yes">PPARGC1A</italic> and <italic toggle="yes">TFCP2</italic>. All detected factors play key roles in liver development and metabolism, for example hepatic nuclear factors, HNF1A and HNF4A (<xref rid="B53" ref-type="bibr">53</xref>), in liver disease pathology such as STAT3 (<xref rid="B54" ref-type="bibr">54</xref>) or in liver regeneration such as CEBPA and CEBPB (<xref rid="B55" ref-type="bibr">55</xref>). We conclude that, combining expression-based gene lists with transcription factor–target sets, can generate valuable hypotheses on transcriptional regulation of the system under study.</p>
    </sec>
    <sec id="SEC3-4">
      <title>Use case 3: putative enhancer regulation of the human cancer signaling network</title>
      <p>ConsensusPathDB offers the possibility to interrogate lists of genes and proteins against enhancer–target gene sets derived from the EnhancerAtlas 2.0 database (<xref rid="B46" ref-type="bibr">46</xref>) that provides such information for 110 human cell lines. Enhancers are known to impact signaling pathways; for example, it has been shown that in cancer cells superenhancers promote oncogene expression and thus mediate dysregulation of several signaling pathways (<xref rid="B56" ref-type="bibr">56</xref>). In order to explore putative enhancer regulation of the cancer signaling network, we used 531 genes contained in the KEGG ‘Pathways in cancer’ network (ID 05200 N). Overrepresentation analysis yields 959 enriched enhancer–target sets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Data S3</xref>; <italic toggle="yes">Q</italic> &lt; 0.05). The corresponding enhancers are highly redundant across the different cell lines. Combining enhancers with the same gene targets yields 17 enhancer clusters that regulate 61 cancer genes. For example, <italic toggle="yes">IL4</italic> (interleukin 4), <italic toggle="yes">IL5</italic> and <italic toggle="yes">IL13</italic> genes are part of enhancer–target sets on chromosome 5 in many different cell lines. The genes are cytokines that are expressed in T helper type 2 cells and they mediate the escape of tumor cells in chronic infection. It has been shown that the expression of these genes is regulated by a genomic enhancer region that is located on chromosome 5 in the 3′ region of the RAD50 gene, which corresponds to the predicted enhancer regions in the different cell lines (<xref rid="B57" ref-type="bibr">57</xref>).</p>
      <p>In order to cross-validate these 17 enhancer clusters and their role in cancer, we compared them against a recent pan-cancer analysis of enhancer expression from The Cancer Genome Atlas (TCGA) Consortium (<xref rid="B58" ref-type="bibr">58</xref>). In this study, enhancer patient gene expression was identified that has prognostic value for survival and 4 out of 17 enhancer clusters identified with the overrepresentation analysis indeed contained prognostic enhancers from the TCGA study. Thus, enhancer–target set enrichment can explore regulatory information inherent in user gene lists.</p>
    </sec>
  </sec>
  <sec id="SEC4">
    <title>INTEGRATING PPIs FOR NETWORK-BASED INFERENCES</title>
    <sec id="SEC4-1">
      <title>PPI confidence assessment and network characterization</title>
      <p>ConsensusPathDB contains a large integrated PPI network comprising 616 304 human interactions (Table <xref rid="tbl1" ref-type="table">1</xref>). Of these, 522 618 are binary interactions composed of exactly two interaction partners; the rest are self-interactions or complex interactions comprising three or more partners. Similar to previous versions, all binary interactions have a numerical score assigned (range [0, 1]; Figure <xref rid="F2" ref-type="fig">2A</xref>). Scores have been computed by integrating several annotation-based and topology-based measures that quantify the confidence associated with each given interaction (<xref rid="B59" ref-type="bibr">59</xref>). In the web interface, these scores are additionally visualized with a ‘traffic light’ icon (green: high confidence &gt;0.95; orange: moderate confidence [0.5–0.95]; red: low confidence &lt;0.5).</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>PPI network characteristics. (<bold>A</bold>) Histogram of confidence scores for the 522 618 human binary interactions in ConsensusPathDB. <italic toggle="yes">X</italic>-axis: confidence score in bins of 0.1; <italic toggle="yes">Y</italic>-axis: number of interactions. (<bold>B</bold>) Histogram of shortest path lengths connecting pairs of nodes in the PPI. (<bold>C</bold>) Node degree distribution of the PPI in log–log scale. <italic toggle="yes">X</italic>-axis: node degree; <italic toggle="yes">Y</italic>-axis: number of nodes. Graphs (B) and (C) were generated with the network analysis function (<xref rid="B60" ref-type="bibr">60</xref>) within the Cytoscape software (<xref rid="B61" ref-type="bibr">61</xref>). (<bold>D</bold>) Scatter plot of degree (<italic toggle="yes">X</italic>-axis) and core (<italic toggle="yes">Y</italic>-axis) of all 19 610 nodes in the PPI. (<bold>E</bold>) Box plot of node core distribution of 3347 recently annotated cancer genes from the Network of Cancer Genes, NCG version 7 (orange) and 3347 randomly selected genes. The <italic toggle="yes">P</italic>-value corresponds to the unpaired Wilcoxon’s rank sum test.</p>
        </caption>
        <graphic xlink:href="gkab1128fig2" position="float"/>
      </fig>
      <p>The integrated PPI network covers 19 610 different human proteins and consists of well-known hubs with very high node degrees &gt;1000 (e.g. MYC with 1932 interactions or TP53 with 1281 interactions; Table <xref rid="tbl2" ref-type="table">2</xref>) and a large number of 6601 proteins with &lt;10 interactions. We analyzed this network further using the network analysis function (<xref rid="B60" ref-type="bibr">60</xref>) within the Cytoscape software (<xref rid="B61" ref-type="bibr">61</xref>). As typical for biological networks, the node degree follows a power law and exhibits a small-world property with a median shortest path of 3 connecting two proteins (Figure <xref rid="F2" ref-type="fig">2B</xref> and <xref rid="F2" ref-type="fig">C</xref>).</p>
      <table-wrap position="float" id="tbl2">
        <label>Table 2.</label>
        <caption>
          <p>Top 30 hub proteins in ConsensusPathDB 2022</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Protein</th>
              <th align="center" rowspan="1" colspan="1">Gene symbol</th>
              <th rowspan="1" colspan="1">Node degree</th>
              <th rowspan="1" colspan="1">Node core</th>
              <th rowspan="1" colspan="1">Cancer gene (NCG V7)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">PKHA4_HUMAN</td>
              <td rowspan="1" colspan="1">PLEKHA4</td>
              <td rowspan="1" colspan="1">2932</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">A4_HUMAN</td>
              <td rowspan="1" colspan="1">APP</td>
              <td rowspan="1" colspan="1">2554</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">ESR2_HUMAN</td>
              <td rowspan="1" colspan="1">ESR2</td>
              <td rowspan="1" colspan="1">2296</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">ESR1_HUMAN</td>
              <td rowspan="1" colspan="1">ESR1</td>
              <td rowspan="1" colspan="1">2200</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">NTRK1_HUMAN</td>
              <td rowspan="1" colspan="1">NTRK1</td>
              <td rowspan="1" colspan="1">1958</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MYC_HUMAN</td>
              <td rowspan="1" colspan="1">MYC</td>
              <td rowspan="1" colspan="1">1932</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">KIF14_HUMAN</td>
              <td rowspan="1" colspan="1">KIF14</td>
              <td rowspan="1" colspan="1">1707</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">H4_HUMAN</td>
              <td rowspan="1" colspan="1">H4C1</td>
              <td rowspan="1" colspan="1">1685</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">JUN_HUMAN</td>
              <td rowspan="1" colspan="1">JUN</td>
              <td rowspan="1" colspan="1">1580</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">EGFR_HUMAN</td>
              <td rowspan="1" colspan="1">EGFR</td>
              <td rowspan="1" colspan="1">1436</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CTRO_HUMAN</td>
              <td rowspan="1" colspan="1">CIT</td>
              <td rowspan="1" colspan="1">1383</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">NR2C2_HUMAN</td>
              <td rowspan="1" colspan="1">NR2C2</td>
              <td rowspan="1" colspan="1">1358</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">RECQ4_HUMAN</td>
              <td rowspan="1" colspan="1">RECQL4</td>
              <td rowspan="1" colspan="1">1353</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">BRD4_HUMAN</td>
              <td rowspan="1" colspan="1">BRD4</td>
              <td rowspan="1" colspan="1">1345</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">U5S1_HUMAN</td>
              <td rowspan="1" colspan="1">EFTUD2</td>
              <td rowspan="1" colspan="1">1345</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">RNF4_HUMAN</td>
              <td rowspan="1" colspan="1">RNF4</td>
              <td rowspan="1" colspan="1">1331</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">BIRC3_HUMAN</td>
              <td rowspan="1" colspan="1">BIRC3</td>
              <td rowspan="1" colspan="1">1324</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">UBC_HUMAN</td>
              <td rowspan="1" colspan="1">UBC</td>
              <td rowspan="1" colspan="1">1324</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">XPO1_HUMAN</td>
              <td rowspan="1" colspan="1">XPO1</td>
              <td rowspan="1" colspan="1">1310</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">P53_HUMAN</td>
              <td rowspan="1" colspan="1">TP53</td>
              <td rowspan="1" colspan="1">1281</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">EGLN3_HUMAN</td>
              <td rowspan="1" colspan="1">EGLN3</td>
              <td rowspan="1" colspan="1">1279</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CUL3_HUMAN</td>
              <td rowspan="1" colspan="1">CUL3</td>
              <td rowspan="1" colspan="1">1229</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">BRCA1_HUMAN</td>
              <td rowspan="1" colspan="1">BRCA1</td>
              <td rowspan="1" colspan="1">1096</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">TIF1B_HUMAN</td>
              <td rowspan="1" colspan="1">TRIM28</td>
              <td rowspan="1" colspan="1">1085</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">GRB2_HUMAN</td>
              <td rowspan="1" colspan="1">GRB2</td>
              <td rowspan="1" colspan="1">1056</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">HD_HUMAN</td>
              <td rowspan="1" colspan="1">HTT</td>
              <td rowspan="1" colspan="1">1036</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PHB_HUMAN</td>
              <td rowspan="1" colspan="1">PHB</td>
              <td rowspan="1" colspan="1">1017</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">KI20A_HUMAN</td>
              <td rowspan="1" colspan="1">KIF20A</td>
              <td rowspan="1" colspan="1">999</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">HSP7C_HUMAN</td>
              <td rowspan="1" colspan="1">HSPA8</td>
              <td rowspan="1" colspan="1">994</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CSN5_HUMAN</td>
              <td rowspan="1" colspan="1">COPS5</td>
              <td rowspan="1" colspan="1">985</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="SEC4-2">
      <title>The PPI as a resource for network propagation</title>
      <p>Network propagation is a theoretical framework for network analyses. It describes a set of analysis tools that use experimental data such as genotype data, expression data or categorical data to initialize node weights and subsequently distribute these weights simultaneously to the network neighborhoods of the nodes (<xref rid="B62" ref-type="bibr">62</xref>). This process converges to a steady state and leads to a re-ranking of the original network nodes. This re-ranking typically amplifies functional associations and is used to identify hotspot subnetworks that agglomerate much of the experimental weights and can be associated with specific biological pathways or parts thereof. Typical applications are to draw inference on genotype–phenotype relations from mutation data (<xref rid="B63" ref-type="bibr">63</xref>) or to identify functional networks from gene and protein expression data (<xref rid="B64" ref-type="bibr">64</xref>). The integrated ConsensusPathDB PPI network is available from the download section of the web server. It has been used in the past as a resource for network propagation (<xref rid="B8" ref-type="bibr">8</xref>), and it has been found as one of the best-performing networks for disease gene identification in an independent benchmark comparison among 21 publicly available networks (<xref rid="B7" ref-type="bibr">7</xref>).</p>
    </sec>
    <sec id="SEC4-3">
      <title>Degree bias in PPI networks</title>
      <p>It should be noted that the ConsensusPathDB PPI network, as many others, contains well-studied protein as hubs (Table <xref rid="tbl2" ref-type="table">2</xref>), which may interfere with network inferences that are based on degree distributions because hubs typically gain a lot of weight in the propagation process because they are highly connected. There are two main biases in PPI networks associated with such hubs: experimental bias and annotation bias. Experimental bias is induced by the way interactions are measured, e.g. Y2H (<xref rid="B65" ref-type="bibr">65</xref>), because these experiments generate star-like structures in interaction graphs with the bait protein as center and prey proteins being connected with the center hub but usually not among themselves. Annotation bias is introduced by the trend to study interactions of already well-studied proteins, which attributes additional links to these hubs and leads to bias in the degree distribution of the PPI (<xref rid="B66" ref-type="bibr">66</xref>).</p>
      <p>Node degree bias in network propagation can be reduced by either better controlling the hubs in the propagation step or taking into account more robust metrics in the re-ranking process. For this purpose, we have developed the network propagation method NetCore (<xref rid="B67" ref-type="bibr">67</xref>). NetCore uses the node core as an alternative node property instead of node degree to conduct the propagation of the experimental weights, which has been found to be more robust against the influence of hubs. Coreness, in contrast to degree, reflects the connectedness of the entire node environment rather than the center hub and thus downweights star-like structures. It is used for identification of influential nodes, i.e. nodes in the core of a network, in contrast to nodes in the periphery of the network. It has been shown that degree and core can be viewed mathematically as start and convergence states of a series of node operators called <italic toggle="yes">H</italic>-indices (<xref rid="B68" ref-type="bibr">68</xref>).</p>
      <p>Although node core is more robust than node degree, both metrics are correlated (Figure <xref rid="F2" ref-type="fig">2D</xref>). In fact, it can be seen that most hubs (Table <xref rid="tbl2" ref-type="table">2</xref>) are in the very inner core of the network and that higher core genes are typically disease genes that are well annotated. To exemplify this, we have investigated the core distribution of 3347 cancer genes and putative cancer genes as identified recently with the network of cancer genes, NCG version 7 (<xref rid="B69" ref-type="bibr">69</xref>). This core distribution is significantly higher than that of 3347 randomly chosen genes (Figure <xref rid="F2" ref-type="fig">2E</xref>; <italic toggle="yes">P</italic> = 3.25e−55), which reflects the fact that cancer genes are very influential in the PPI network, on the one hand, because they are intensively studied and, on the other hand, because they are highly connected and participate at multiple cellular processes.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC5">
    <title>CONCLUSION</title>
    <p>Through the integration of 31 human public interaction/pathway resources, ConsensusPathDB assembles one of the most comprehensive available maps of human interactions and pathways. Viewing and analyzing molecular data in the context of heterogeneous interactions allows detecting cellular mechanisms across annotation domains, which is essential in the interpretation of contemporary types of complex high-throughput data. The content increase updates the system with the most widely used interaction databases and the inclusion of regulatory gene sets for data interpretation opens a novel path for functional analysis and interpretation of gene lists. Additionally, the PPI network provides a valuable resource for network biology.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC6">
    <title>DATA AVAILABILITY</title>
    <p>ConsensusPathDB is freely accessible through the web server at <ext-link xlink:href="http://consensuspathdb.org" ext-link-type="uri">http://consensuspathdb.org</ext-link>. All agglomerated interactions and pathway gene sets can be downloaded in the download section.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkab1128_Supplemental_Files</label>
      <media xlink:href="gkab1128_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We are grateful to the developers and annotators of all source databases who have provided interaction data to the public domain. We would also like to thank the ConsensusPathDB users who have provided valuable feedback throughout the years. ConsensusPathDB is exclusively developed with open-source software whose contributors are gratefully acknowledged.</p>
  </ack>
  <sec id="SEC7">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkab1128#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC8">
    <title>FUNDING</title>
    <p>German Federal Ministry of Education and Research [161L0242A]; European Commission Horizon 2020 Framework Programme [811034]; Max Planck Society. Funding for open access charge: German Federal Ministry of Education and Research.</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. A. Kamburov is an employee of Bayer AG.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Haniffa</surname><given-names>M.</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>D.</given-names></string-name>, <string-name><surname>Linnarsson</surname><given-names>S.</given-names></string-name>, <string-name><surname>Aronow</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Bader</surname><given-names>G.D.</given-names></string-name>, <string-name><surname>Barker</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Camara</surname><given-names>P.G.</given-names></string-name>, <string-name><surname>Camp</surname><given-names>J.G.</given-names></string-name>, <string-name><surname>Chédotal</surname><given-names>A.</given-names></string-name>, <string-name><surname>Copp</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A roadmap for the human developmental cell atlas</article-title>. <source>Nature</source>. <year>2021</year>; <volume>597</volume>:<fpage>196</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="pmid">34497388</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lichtenberg</surname><given-names>T.</given-names></string-name>, <string-name><surname>Hoadley</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Poisson</surname><given-names>L.M.</given-names></string-name>, <string-name><surname>Lazar</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Cherniack</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Kovatich</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Benz</surname><given-names>C.C.</given-names></string-name>, <string-name><surname>Levine</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>A.V.</given-names></string-name><etal>et al</etal>.</person-group><article-title>An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics</article-title>. <source>Cell</source>. <year>2018</year>; <volume>173</volume>:<fpage>400</fpage>–<lpage>416</lpage>.<pub-id pub-id-type="pmid">29625055</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bader</surname><given-names>G.D.</given-names></string-name>, <string-name><surname>Cary</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Sander</surname><given-names>C.</given-names></string-name></person-group><article-title>Pathguide: a pathway resource list</article-title>. <source>Nucleic Acids Res.</source><year>2006</year>; <volume>34</volume>:<fpage>D504</fpage>–<lpage>D506</lpage>.<pub-id pub-id-type="pmid">16381921</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mubeen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hoyt</surname><given-names>C.T.</given-names></string-name>, <string-name><surname>Gemünd</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hofmann-Apitius</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fröhlich</surname><given-names>H.</given-names></string-name>, <string-name><surname>Domingo-Fernández</surname><given-names>D.</given-names></string-name></person-group><article-title>The impact of pathway database choice on statistical enrichment analysis and predictive modeling</article-title>. <source>Front. Genet.</source><year>2019</year>; <volume>10</volume>:<fpage>1203</fpage>.<pub-id pub-id-type="pmid">31824580</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kamburov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Stelzl</surname><given-names>U.</given-names></string-name>, <string-name><surname>Lehrach</surname><given-names>H.</given-names></string-name>, <string-name><surname>Herwig</surname><given-names>R.</given-names></string-name></person-group><article-title>The ConsensusPathDB interaction database: 2013 update</article-title>. <source>Nucleic Acids Res.</source><year>2013</year>; <volume>41</volume>:<fpage>D793</fpage>–<lpage>D800</lpage>.<pub-id pub-id-type="pmid">23143270</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herwig</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hardt</surname><given-names>C.</given-names></string-name>, <string-name><surname>Lienhard</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kamburov</surname><given-names>A.</given-names></string-name></person-group><article-title>Analyzing and interpreting genome data at the network level with ConsensusPathDB</article-title>. <source>Nat. Protoc.</source><year>2016</year>; <volume>11</volume>:<fpage>1889</fpage>–<lpage>1907</lpage>.<pub-id pub-id-type="pmid">27606777</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Carlin</surname><given-names>D.E.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>M.K.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Kreisberg</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Tamayo</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ideker</surname><given-names>T.</given-names></string-name></person-group><article-title>Systematic evaluation of molecular networks for discovery of disease genes</article-title>. <source>Cell Syst.</source><year>2018</year>; <volume>6</volume>:<fpage>484</fpage>–<lpage>495</lpage>.<pub-id pub-id-type="pmid">29605183</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Selevsek</surname><given-names>N.</given-names></string-name>, <string-name><surname>Caiment</surname><given-names>F.</given-names></string-name>, <string-name><surname>Nudischer</surname><given-names>R.</given-names></string-name>, <string-name><surname>Gmuender</surname><given-names>H.</given-names></string-name>, <string-name><surname>Agarkova</surname><given-names>I.</given-names></string-name>, <string-name><surname>Atkinson</surname><given-names>F.L.</given-names></string-name>, <string-name><surname>Bachmann</surname><given-names>I.</given-names></string-name>, <string-name><surname>Baier</surname><given-names>V.</given-names></string-name>, <string-name><surname>Barel</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bauer</surname><given-names>C.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Network integration and modelling of dynamic drug responses at multi-omics levels</article-title>. <source>Commun. Biol.</source><year>2020</year>; <volume>3</volume>:<fpage>573</fpage>.<pub-id pub-id-type="pmid">33060801</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><collab>The Gene Ontology Consortium</collab><article-title>The Gene Ontology resource: enriching a GOld mine</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D325</fpage>–<lpage>D334</lpage>.<pub-id pub-id-type="pmid">33290552</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bader</surname><given-names>G.D.</given-names></string-name>, <string-name><surname>Betel</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hogue</surname><given-names>C.W.</given-names></string-name></person-group><article-title>BIND: the biomolecular interaction network database</article-title>. <source>Nucleic Acids Res.</source><year>2003</year>; <volume>31</volume>:<fpage>248</fpage>–<lpage>250</lpage>.<pub-id pub-id-type="pmid">12519993</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rouillard</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Gundersen</surname><given-names>G.W.</given-names></string-name>, <string-name><surname>Fernandez</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Monteiro</surname><given-names>C.D.</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Ma’ayan</surname><given-names>A.</given-names></string-name></person-group><article-title>The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins</article-title>. <source>Database</source>. <year>2016</year>; <volume>2016</volume>:<fpage>baw100</fpage>.<pub-id pub-id-type="pmid">27374120</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stark</surname><given-names>C.</given-names></string-name>, <string-name><surname>Breitkreutz</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Reguly</surname><given-names>T.</given-names></string-name>, <string-name><surname>Boucher</surname><given-names>L.</given-names></string-name>, <string-name><surname>Breitkreutz</surname><given-names>A.</given-names></string-name>, <string-name><surname>Tyers</surname><given-names>M.</given-names></string-name></person-group><article-title>Biogrid: a general repository for interaction datasets</article-title>. <source>Nucleic Acids Res.</source><year>2006</year>; <volume>34</volume>:<fpage>D535</fpage>–<lpage>D539</lpage>.<pub-id pub-id-type="pmid">16381927</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giurgiu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Reinhard</surname><given-names>J.</given-names></string-name>, <string-name><surname>Brauner</surname><given-names>B.</given-names></string-name>, <string-name><surname>Dunger-Kaltenbach</surname><given-names>I.</given-names></string-name>, <string-name><surname>Fobo</surname><given-names>G.</given-names></string-name>, <string-name><surname>Frishman</surname><given-names>G.</given-names></string-name>, <string-name><surname>Montrone</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ruepp</surname><given-names>A.</given-names></string-name></person-group><article-title>CORUM: the comprehensive resource of mammalian protein complexes—2019</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D559</fpage>–<lpage>D563</lpage>.<pub-id pub-id-type="pmid">30357367</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mendez</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gaulton</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bento</surname><given-names>A.P.</given-names></string-name>, <string-name><surname>Chambers</surname><given-names>J.</given-names></string-name>, <string-name><surname>DeVeij</surname><given-names>M.</given-names></string-name>, <string-name><surname>Félix</surname><given-names>E.</given-names></string-name>, <string-name><surname>Magariños</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Mosquera</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Mutowo</surname><given-names>P.</given-names></string-name>, <string-name><surname>Nowotka</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ChEMBL: towards direct deposition of bioassay data</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>8</volume>:<fpage>D930</fpage>–<lpage>D940</lpage>.</mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salwinski</surname><given-names>L.</given-names></string-name>, <string-name><surname>Miller</surname><given-names>C.S.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Pettit</surname><given-names>F.K.</given-names></string-name>, <string-name><surname>Bowie</surname><given-names>J.U.</given-names></string-name>, <string-name><surname>Eisenberg</surname><given-names>D.</given-names></string-name></person-group><article-title>The database of interacting proteins: 2004 update</article-title>. <source>Nucleic Acids Res.</source><year>2004</year>; <volume>32</volume>:<fpage>D449</fpage>–<lpage>D451</lpage>.<pub-id pub-id-type="pmid">14681454</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname><given-names>H.</given-names></string-name>, <string-name><surname>Sorokin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Mazein</surname><given-names>A.</given-names></string-name>, <string-name><surname>Selkov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Selkov</surname><given-names>E.</given-names></string-name>, <string-name><surname>Demin</surname><given-names>O.</given-names></string-name>, <string-name><surname>Goryanin</surname><given-names>I.</given-names></string-name></person-group><article-title>The Edinburgh human metabolic network reconstruction and its functional analysis</article-title>. <source>Mol. Syst. Biol.</source><year>2007</year>; <volume>3</volume>:<fpage>135</fpage>.<pub-id pub-id-type="pmid">17882155</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Keshava Prasad</surname><given-names>T.S.</given-names></string-name>, <string-name><surname>Goel</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kandasamy</surname><given-names>K.</given-names></string-name>, <string-name><surname>Keerthikumar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kumar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Mathivanan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Telikicherla</surname><given-names>D.</given-names></string-name>, <string-name><surname>Raju</surname><given-names>R.</given-names></string-name>, <string-name><surname>Shafreen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Venugopal</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Human Protein Reference Database—2009 update</article-title>. <source>Nucleic Acids Res.</source><year>2009</year>; <volume>37</volume>:<fpage>D767</fpage>–<lpage>D772</lpage>.<pub-id pub-id-type="pmid">18988627</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karp</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Billington</surname><given-names>R.</given-names></string-name>, <string-name><surname>Caspi</surname><given-names>R.</given-names></string-name>, <string-name><surname>Fulcher</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Latendresse</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kothari</surname><given-names>A.</given-names></string-name>, <string-name><surname>Keseler</surname><given-names>I.M.</given-names></string-name>, <string-name><surname>Krummenacker</surname><given-names>M.</given-names></string-name>, <string-name><surname>Midford</surname><given-names>P.E.</given-names></string-name>, <string-name><surname>Ong</surname><given-names>Q.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The BioCyc collection of microbial genomes and metabolic pathways</article-title>. <source>Brief. Bioinform.</source><year>2017</year>; <volume>20</volume>:<fpage>1085</fpage>–<lpage>1093</lpage>.</mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamamoto</surname><given-names>S.</given-names></string-name>, <string-name><surname>Sakai</surname><given-names>N.</given-names></string-name>, <string-name><surname>Nakamura</surname><given-names>H.</given-names></string-name>, <string-name><surname>Fukagawa</surname><given-names>H.</given-names></string-name>, <string-name><surname>Fukuda</surname><given-names>K.</given-names></string-name>, <string-name><surname>Takagi</surname><given-names>T.</given-names></string-name></person-group><article-title>INOH: ontology-based highly structured database of signal transduction pathways</article-title>. <source>Database</source>. <year>2011</year>; <volume>2011</volume>:<fpage>bar052</fpage>.<pub-id pub-id-type="pmid">22120663</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breuer</surname><given-names>K.</given-names></string-name>, <string-name><surname>Foroushani</surname><given-names>A.K.</given-names></string-name>, <string-name><surname>Laird</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>C.</given-names></string-name>, <string-name><surname>Sribnaia</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lo</surname><given-names>R.</given-names></string-name>, <string-name><surname>Winsor</surname><given-names>G.L.</given-names></string-name>, <string-name><surname>Hancock</surname><given-names>R.E.</given-names></string-name>, <string-name><surname>Brinkman</surname><given-names>F.S.</given-names></string-name>, <string-name><surname>Lynn</surname><given-names>D.J.</given-names></string-name></person-group><article-title>InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation</article-title>. <source>Nucleic Acids Res.</source><year>2013</year>; <volume>41</volume>:<fpage>D1228</fpage>–<lpage>D1233</lpage>.<pub-id pub-id-type="pmid">23180781</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Orchard</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ammari</surname><given-names>M.</given-names></string-name>, <string-name><surname>Aranda</surname><given-names>B.</given-names></string-name>, <string-name><surname>Breuza</surname><given-names>L.</given-names></string-name>, <string-name><surname>Briganti</surname><given-names>L.</given-names></string-name>, <string-name><surname>Broackes-Carter</surname><given-names>F.</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>N.H.</given-names></string-name>, <string-name><surname>Chavali</surname><given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>C.</given-names></string-name>, <string-name><surname>del-Toro</surname><given-names>N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>42</volume>:<fpage>D358</fpage>–<lpage>D363</lpage>.<pub-id pub-id-type="pmid">24234451</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kanehisa</surname><given-names>M.</given-names></string-name>, <string-name><surname>Furumichi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tanabe</surname><given-names>M.</given-names></string-name>, <string-name><surname>Sato</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Morishima</surname><given-names>K.</given-names></string-name></person-group><article-title>KEGG: new perspectives on genomes, pathways, diseases and drugs</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D353</fpage>–<lpage>D361</lpage>.<pub-id pub-id-type="pmid">27899662</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Licata</surname><given-names>L.</given-names></string-name>, <string-name><surname>Briganti</surname><given-names>L.</given-names></string-name>, <string-name><surname>Peluso</surname><given-names>D.</given-names></string-name>, <string-name><surname>Perfetto</surname><given-names>L.</given-names></string-name>, <string-name><surname>Iannuccelli</surname><given-names>M.</given-names></string-name>, <string-name><surname>Galeota</surname><given-names>E.</given-names></string-name>, <string-name><surname>Sacco</surname><given-names>F.</given-names></string-name>, <string-name><surname>Palma</surname><given-names>A.</given-names></string-name>, <string-name><surname>Nardozza</surname><given-names>A.P.</given-names></string-name>, <string-name><surname>Santonico</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>MINT, the molecular interaction database: 2012 update</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>; <volume>40</volume>:<fpage>D857</fpage>–<lpage>D861</lpage>.<pub-id pub-id-type="pmid">22096227</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pagel</surname><given-names>P.</given-names></string-name>, <string-name><surname>Kovac</surname><given-names>S.</given-names></string-name>, <string-name><surname>Oesterheld</surname><given-names>M.</given-names></string-name>, <string-name><surname>Brauner</surname><given-names>B.</given-names></string-name>, <string-name><surname>Dunger-Kaltenbach</surname><given-names>I.</given-names></string-name>, <string-name><surname>Frishman</surname><given-names>G.</given-names></string-name>, <string-name><surname>Montrone</surname><given-names>C.</given-names></string-name>, <string-name><surname>Mark</surname><given-names>P.</given-names></string-name>, <string-name><surname>Stümpflen</surname><given-names>V.</given-names></string-name>, <string-name><surname>Mewes</surname><given-names>H.W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The MIPS mammalian protein–protein interaction database</article-title>. <source>Bioinformatics</source>. <year>2005</year>; <volume>21</volume>:<fpage>832</fpage>–<lpage>834</lpage>.<pub-id pub-id-type="pmid">15531608</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clerc</surname><given-names>O.</given-names></string-name>, <string-name><surname>Deniaud</surname><given-names>M.</given-names></string-name>, <string-name><surname>Vallet</surname><given-names>S.D.</given-names></string-name>, <string-name><surname>Naba</surname><given-names>A.</given-names></string-name>, <string-name><surname>Rivet</surname><given-names>A.</given-names></string-name>, <string-name><surname>Perez</surname><given-names>S.</given-names></string-name>, <string-name><surname>Thierry-Mieg</surname><given-names>N.</given-names></string-name>, <string-name><surname>Ricard-Blum</surname><given-names>S.</given-names></string-name></person-group><article-title>MatrixDB: integration of new data with a focus on glycosaminoglycan interactions</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D376</fpage>–<lpage>D381</lpage>.<pub-id pub-id-type="pmid">30371822</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kandasamy</surname><given-names>K.</given-names></string-name>, <string-name><surname>Mohan</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Raju</surname><given-names>R.</given-names></string-name>, <string-name><surname>Keerthikumar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kumar</surname><given-names>G.S.</given-names></string-name>, <string-name><surname>Venugopal</surname><given-names>A.K.</given-names></string-name>, <string-name><surname>Telikicherla</surname><given-names>D.</given-names></string-name>, <string-name><surname>Navarro</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Mathivanan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Pecquet</surname><given-names>C.</given-names></string-name><etal>et al</etal>.</person-group><article-title>NetPath: a public resource of curated signal transduction pathways</article-title>. <source>Genome Biol.</source><year>2010</year>; <volume>11</volume>:<fpage>R3</fpage>.<pub-id pub-id-type="pmid">20067622</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burley</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Bhikadiya</surname><given-names>C.</given-names></string-name>, <string-name><surname>Bi</surname><given-names>C.</given-names></string-name>, <string-name><surname>Bittrich</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Crichlow</surname><given-names>G.V.</given-names></string-name>, <string-name><surname>Christie</surname><given-names>C.H.</given-names></string-name>, <string-name><surname>Dalenberg</surname><given-names>K.</given-names></string-name>, <string-name><surname>Di Costanzo</surname><given-names>L.</given-names></string-name>, <string-name><surname>Duarte</surname><given-names>J.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D437</fpage>–<lpage>D451</lpage>.<pub-id pub-id-type="pmid">33211854</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beuming</surname><given-names>T.</given-names></string-name>, <string-name><surname>Skrabanek</surname><given-names>L.</given-names></string-name>, <string-name><surname>Niv</surname><given-names>M.Y.</given-names></string-name>, <string-name><surname>Mukherjee</surname><given-names>P.</given-names></string-name>, <string-name><surname>Weinstein</surname><given-names>H.</given-names></string-name></person-group><article-title>PDZBase: a protein–protein interaction database for PDZ-domains</article-title>. <source>Bioinformatics</source>. <year>2005</year>; <volume>21</volume>:<fpage>827</fpage>–<lpage>828</lpage>.<pub-id pub-id-type="pmid">15513994</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaefer</surname><given-names>C.F.</given-names></string-name>, <string-name><surname>Anthony</surname><given-names>K.</given-names></string-name>, <string-name><surname>Krupa</surname><given-names>S.</given-names></string-name>, <string-name><surname>Buchoff</surname><given-names>J.</given-names></string-name>, <string-name><surname>Day</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hannay</surname><given-names>T.</given-names></string-name>, <string-name><surname>Buetow</surname><given-names>K.H.</given-names></string-name></person-group><article-title>PID: the pathway interaction database</article-title>. <source>Nucleic Acids Res.</source><year>2009</year>; <volume>37</volume>:<fpage>D674</fpage>–<lpage>D679</lpage>.<pub-id pub-id-type="pmid">18832364</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Driscoll</surname><given-names>T.</given-names></string-name>, <string-name><surname>Dyer</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Murali</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Sobral</surname><given-names>B.W.</given-names></string-name></person-group><article-title>PIG—the pathogen interaction gateway</article-title>. <source>Nucleic Acids Res.</source><year>2009</year>; <volume>37</volume>:<fpage>D647</fpage>–<lpage>D650</lpage>.<pub-id pub-id-type="pmid">18984614</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luc</surname><given-names>P.V.</given-names></string-name>, <string-name><surname>Tempst</surname><given-names>P.</given-names></string-name></person-group><article-title>PINdb: a database of nuclear protein complexes from human and yeast</article-title>. <source>Bioinformatics</source>. <year>2004</year>; <volume>20</volume>:<fpage>1413</fpage>–<lpage>1415</lpage>.<pub-id pub-id-type="pmid">15087322</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Whirl-Carrillo</surname><given-names>M.</given-names></string-name>, <string-name><surname>McDonagh</surname><given-names>E.M.</given-names></string-name>, <string-name><surname>Hebert</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>L.</given-names></string-name>, <string-name><surname>Sangkuhl</surname><given-names>K.</given-names></string-name>, <string-name><surname>Thorn</surname><given-names>C.F.</given-names></string-name>, <string-name><surname>Altman</surname><given-names>R.B.</given-names></string-name>, <string-name><surname>Klein</surname><given-names>T.E.</given-names></string-name></person-group><article-title>Pharmacogenomics knowledge for personalized medicine</article-title>. <source>Clin. Pharmacol. Ther.</source><year>2012</year>; <volume>92</volume>:<fpage>414</fpage>–<lpage>417</lpage>.<pub-id pub-id-type="pmid">22992668</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>C.H.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Y.L.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>T.C.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Yen</surname><given-names>C.C.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Hong</surname><given-names>Y.R.</given-names></string-name>, <string-name><surname>Tseng</surname><given-names>T.L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>PhosphoPOINT: a comprehensive human kinase interactome and phospho-protein database</article-title>. <source>Bioinformatics</source>. <year>2008</year>; <volume>24</volume>:<fpage>i14</fpage>–<lpage>i20</lpage>.<pub-id pub-id-type="pmid">18689816</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hornbeck</surname><given-names>P.V.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Murray</surname><given-names>B.</given-names></string-name>, <string-name><surname>Kornhauser</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Latham</surname><given-names>V.</given-names></string-name>, <string-name><surname>Skrzypek</surname><given-names>E.</given-names></string-name></person-group><article-title>PhosphoSitePlus, 2014: mutations, PTMs and recalibrations</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>D512</fpage>–<lpage>D520</lpage>.<pub-id pub-id-type="pmid">25514926</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jassal</surname><given-names>B.</given-names></string-name>, <string-name><surname>Matthews</surname><given-names>L.</given-names></string-name>, <string-name><surname>Viteri</surname><given-names>G.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>C.</given-names></string-name>, <string-name><surname>Lorente</surname><given-names>P.</given-names></string-name>, <string-name><surname>Fabregat</surname><given-names>A.</given-names></string-name>, <string-name><surname>Sidiropoulos</surname><given-names>K.</given-names></string-name>, <string-name><surname>Cook</surname><given-names>J.</given-names></string-name>, <string-name><surname>Gillespie</surname><given-names>M.</given-names></string-name>, <string-name><surname>Haw</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Reactome pathway knowledgebase</article-title>. <source>Nucleic Acids Res.</source><volume>48</volume>:<fpage>D498</fpage>–<lpage>D503</lpage>.<pub-id pub-id-type="pmid">31691815</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jewison</surname><given-names>T.</given-names></string-name>, <string-name><surname>Su</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Disfany</surname><given-names>F.M.</given-names></string-name>, <string-name><surname>Liang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Knox</surname><given-names>C.</given-names></string-name>, <string-name><surname>Maciejewski</surname><given-names>A.</given-names></string-name>, <string-name><surname>Poelzer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Huynh</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Arndt</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>SMPDB 2.0: big improvements to the Small Molecule Pathway Database</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>42</volume>:<fpage>D478</fpage>–<lpage>D484</lpage>.<pub-id pub-id-type="pmid">24203708</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fazekas</surname><given-names>D.</given-names></string-name>, <string-name><surname>Koltai</surname><given-names>M.</given-names></string-name>, <string-name><surname>Türei</surname><given-names>D.</given-names></string-name>, <string-name><surname>Módos</surname><given-names>D.</given-names></string-name>, <string-name><surname>Pálfy</surname><given-names>M.</given-names></string-name>, <string-name><surname>Dúl</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zsákai</surname><given-names>L.</given-names></string-name>, <string-name><surname>Szalay-Bekő</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lenti</surname><given-names>K.</given-names></string-name>, <string-name><surname>Farkas</surname><given-names>I.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>SignaLink 2.0: a signaling pathway resource with multi-layered regulatory networks</article-title>. <source>BMC Syst. Biol.</source><year>2013</year>; <volume>7</volume>:<fpage>7</fpage>.<pub-id pub-id-type="pmid">23331499</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paz</surname><given-names>A.</given-names></string-name>, <string-name><surname>Brownstein</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Ber</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Bialik</surname><given-names>S.</given-names></string-name>, <string-name><surname>David</surname><given-names>E.</given-names></string-name>, <string-name><surname>Sagir</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ulitsky</surname><given-names>I.</given-names></string-name>, <string-name><surname>Elkon</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kimchi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Avraham</surname><given-names>K.B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>SPIKE: a database of highly curated human signaling pathways</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>; <volume>39</volume>:<fpage>D793</fpage>–<lpage>D799</lpage>.<pub-id pub-id-type="pmid">21097778</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D1031</fpage>–<lpage>D1041</lpage>.<pub-id pub-id-type="pmid">31691823</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martens</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ammar</surname><given-names>A.</given-names></string-name>, <string-name><surname>Riutta</surname><given-names>A.</given-names></string-name>, <string-name><surname>Waagmeester</surname><given-names>A.</given-names></string-name>, <string-name><surname>Slenter</surname><given-names>D.N.</given-names></string-name>, <string-name><surname>Hanspers</surname><given-names>K.</given-names></string-name>, <string-name><surname>Miller</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Digles</surname><given-names>D.</given-names></string-name>, <string-name><surname>Lopes</surname><given-names>E.N.</given-names></string-name>, <string-name><surname>Ehrhart</surname><given-names>F.</given-names></string-name><etal>et al</etal>.</person-group><article-title>WikiPathways: connecting communities</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D613</fpage>–<lpage>D621</lpage>.<pub-id pub-id-type="pmid">33211851</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kamburov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Pentchev</surname><given-names>K.</given-names></string-name>, <string-name><surname>Galicka</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wierling</surname><given-names>C.</given-names></string-name>, <string-name><surname>Lehrach</surname><given-names>H.</given-names></string-name>, <string-name><surname>Herwig</surname><given-names>R.</given-names></string-name></person-group><article-title>ConsensusPathDB: toward a more complete picture of cell biology</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>; <volume>39</volume>:<fpage>D712</fpage>–<lpage>D717</lpage>.<pub-id pub-id-type="pmid">21071422</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agarwal</surname><given-names>V.</given-names></string-name>, <string-name><surname>Bell</surname><given-names>G.W.</given-names></string-name>, <string-name><surname>Nam</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Bartel</surname><given-names>D.P.</given-names></string-name></person-group><article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>. <source>eLife</source>. <year>2015</year>; <volume>4</volume>:<fpage>e05005</fpage>.</mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>H.Y.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>Y.C.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>K.Y</given-names></string-name>, <string-name><surname>Shrestha</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hong</surname><given-names>H.C.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.G.</given-names></string-name>, <string-name><surname>Jin</surname><given-names>C.N.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D148</fpage>–<lpage>D154</lpage>.<pub-id pub-id-type="pmid">31647101</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.</given-names></string-name></person-group><article-title>miRDB: an online database for prediction of functional microRNA targets</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D127</fpage>–<lpage>D131</lpage>.<pub-id pub-id-type="pmid">31504780</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Han</surname><given-names>H.</given-names></string-name>, <string-name><surname>Cho</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S.</given-names></string-name>, <string-name><surname>Yun</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>H.</given-names></string-name>, <string-name><surname>Bae</surname><given-names>D.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>D380</fpage>–<lpage>D386</lpage>.<pub-id pub-id-type="pmid">29087512</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>T.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>J.</given-names></string-name></person-group><article-title>EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue/cell types across nine species</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D58</fpage>–<lpage>D64</lpage>.<pub-id pub-id-type="pmid">31740966</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Friedmann</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Nunnari</surname><given-names>J.</given-names></string-name></person-group><article-title>Mitochondrial form and function</article-title>. <source>Nature</source>. <year>2014</year>; <volume>505</volume>:<fpage>335</fpage>–<lpage>343</lpage>.<pub-id pub-id-type="pmid">24429632</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bonauer</surname><given-names>A.</given-names></string-name>, <string-name><surname>Carmona</surname><given-names>G.</given-names></string-name>, <string-name><surname>Iwasaki</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mione</surname><given-names>M.</given-names></string-name>, <string-name><surname>Koyanagi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fischer</surname><given-names>A.</given-names></string-name>, <string-name><surname>Burchfield</surname><given-names>J.</given-names></string-name>, <string-name><surname>Fox</surname><given-names>H.</given-names></string-name>, <string-name><surname>Doebele</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ohtani</surname><given-names>K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice</article-title>. <source>Science</source>. <year>2009</year>; <volume>324</volume>:<fpage>1710</fpage>–<lpage>1713</lpage>.<pub-id pub-id-type="pmid">19460962</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>J.</given-names></string-name>, <string-name><surname>Song</surname><given-names>J.</given-names></string-name></person-group><article-title>MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM</article-title>. <source>J. Transl. Med.</source><year>2018</year>; <volume>16</volume>:<fpage>161</fpage>.<pub-id pub-id-type="pmid">29885652</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rigaud</surname><given-names>V.O.</given-names></string-name>, <string-name><surname>Ferreira</surname><given-names>L.R.</given-names></string-name>, <string-name><surname>Ayub-Ferreira</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Ávila</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Brandão</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Cruz</surname><given-names>F.D.</given-names></string-name>, <string-name><surname>Santos</surname><given-names>M.H.</given-names></string-name>, <string-name><surname>Cruz</surname><given-names>C.B.</given-names></string-name>, <string-name><surname>Alves</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Issa</surname><given-names>V.S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients</article-title>. <source>Oncotarget</source>. <year>2017</year>; <volume>8</volume>:<fpage>6994</fpage>–<lpage>7002</lpage>.<pub-id pub-id-type="pmid">28052002</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sonawane</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Platig</surname><given-names>J.</given-names></string-name>, <string-name><surname>Fagny</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Paulson</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Lopes-Ramos</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>DeMeo</surname><given-names>D.L.</given-names></string-name>, <string-name><surname>Quackenbush</surname><given-names>J.</given-names></string-name>, <string-name><surname>Glass</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kuijjer</surname><given-names>M.L.</given-names></string-name></person-group><article-title>Understanding tissue-specific gene regulation</article-title>. <source>Cell Rep.</source><year>2017</year>; <volume>21</volume>:<fpage>1077</fpage>–<lpage>1088</lpage>.<pub-id pub-id-type="pmid">29069589</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><collab>GTEx Consortium</collab><article-title>The Genotype-Tissue Expression (GTEx) project</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>580</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">23715323</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Odom</surname><given-names>D.T.</given-names></string-name>, <string-name><surname>Dowell</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Jacobsen</surname><given-names>E.S.</given-names></string-name>, <string-name><surname>Nekludova</surname><given-names>L.</given-names></string-name>, <string-name><surname>Rolfe</surname><given-names>P.A.</given-names></string-name>, <string-name><surname>Danford</surname><given-names>T.W.</given-names></string-name>, <string-name><surname>Gifford</surname><given-names>D.K.</given-names></string-name>, <string-name><surname>Fraenkel</surname><given-names>E.</given-names></string-name>, <string-name><surname>Bell</surname><given-names>G.I.</given-names></string-name>, <string-name><surname>Young</surname><given-names>R.A.</given-names></string-name></person-group><article-title>Core transcriptional regulatory circuitry in human hepatocytes</article-title>. <source>Mol. Syst. Biol.</source><year>2006</year>; <volume>2</volume>:<fpage>2006.0017</fpage>.</mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>J.</given-names></string-name>, <string-name><surname>Qi</surname><given-names>Y.F.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Y.R.</given-names></string-name></person-group><article-title>STAT3: a key regulator in liver fibrosis</article-title>. <source>Ann. Hepatol.</source><year>2021</year>; <volume>21</volume>:<fpage>100224</fpage>.<pub-id pub-id-type="pmid">32702499</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jakobsen</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Waage</surname><given-names>J.</given-names></string-name>, <string-name><surname>Rapin</surname><given-names>N.</given-names></string-name>, <string-name><surname>Bisgaard</surname><given-names>H.C.</given-names></string-name>, <string-name><surname>Larsen</surname><given-names>F.S.</given-names></string-name>, <string-name><surname>Porse</surname><given-names>B.T.</given-names></string-name></person-group><article-title>Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteries</article-title>. <source>Genome Res.</source><year>2013</year>; <volume>23</volume>:<fpage>592</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">23403033</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hnisz</surname><given-names>D.</given-names></string-name>, <string-name><surname>Schuijers</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Weintraub</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Abraham</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>T.I.</given-names></string-name>, <string-name><surname>Bradner</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Young</surname><given-names>R.A.</given-names></string-name></person-group><article-title>Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers</article-title>. <source>Mol. Cell</source>. <year>2015</year>; <volume>58</volume>:<fpage>362</fpage>–<lpage>370</lpage>.<pub-id pub-id-type="pmid">25801169</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fields</surname><given-names>P.E.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>S.T.</given-names></string-name>, <string-name><surname>Bartsevich</surname><given-names>V.V.</given-names></string-name>, <string-name><surname>Flavell</surname><given-names>R.A.</given-names></string-name></person-group><article-title>Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region</article-title>. <source>Immunity</source>. <year>2004</year>; <volume>21</volume>:<fpage>865</fpage>–<lpage>876</lpage>.<pub-id pub-id-type="pmid">15589174</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Weinstein</surname><given-names>J.N.</given-names></string-name><collab>Cancer Genome Atlas Research Network Cancer Genome Atlas Research Network</collab><string-name><surname>Liang</surname><given-names>H.</given-names></string-name></person-group><article-title>A pan-cancer analysis of enhancer expression in nearly 9000 patient samples</article-title>. <source>Cell</source>. <year>2018</year>; <volume>173</volume>:<fpage>386</fpage>–<lpage>399</lpage>.<pub-id pub-id-type="pmid">29625054</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kamburov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Stelzl</surname><given-names>U.</given-names></string-name>, <string-name><surname>Herwig</surname><given-names>R.</given-names></string-name></person-group><article-title>IntScore: a web tool for confidence scoring of biological interactions</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>; <volume>40</volume>:<fpage>W140</fpage>–<lpage>W146</lpage>.<pub-id pub-id-type="pmid">22649056</pub-id></mixed-citation>
    </ref>
    <ref id="B60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Assenov</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ramírez</surname><given-names>F.</given-names></string-name>, <string-name><surname>Schelhorn</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Lengauer</surname><given-names>T.</given-names></string-name>, <string-name><surname>Albrecht</surname><given-names>M.</given-names></string-name></person-group><article-title>Computing topological parameters of biological networks</article-title>. <source>Bioinformatics</source>. <year>2008</year>; <volume>24</volume>:<fpage>282</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">18006545</pub-id></mixed-citation>
    </ref>
    <ref id="B61">
      <label>61.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cline</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Smoot</surname><given-names>M.</given-names></string-name>, <string-name><surname>Cerami</surname><given-names>E.</given-names></string-name>, <string-name><surname>Kuchinsky</surname><given-names>A.</given-names></string-name>, <string-name><surname>Landys</surname><given-names>N.</given-names></string-name>, <string-name><surname>Workman</surname><given-names>C.</given-names></string-name>, <string-name><surname>Christmas</surname><given-names>R.</given-names></string-name>, <string-name><surname>Avila-Campilo</surname><given-names>I.</given-names></string-name>, <string-name><surname>Creech</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gross</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Integration of biological networks and gene expression data using Cytoscape</article-title>. <source>Nat. Protoc.</source><year>2007</year>; <volume>2</volume>:<fpage>2366</fpage>–<lpage>2382</lpage>.<pub-id pub-id-type="pmid">17947979</pub-id></mixed-citation>
    </ref>
    <ref id="B62">
      <label>62.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cowen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ideker</surname><given-names>T.</given-names></string-name>, <string-name><surname>Raphael</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Sharan</surname><given-names>R.</given-names></string-name></person-group><article-title>Network propagation: a universal amplifier of genetic associations</article-title>. <source>Nat. Rev. Genet.</source><year>2017</year>; <volume>18</volume>:<fpage>551</fpage>–<lpage>562</lpage>.<pub-id pub-id-type="pmid">28607512</pub-id></mixed-citation>
    </ref>
    <ref id="B63">
      <label>63.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leiserson</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Vandin</surname><given-names>F.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>H.T.</given-names></string-name>, <string-name><surname>Dobson</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Eldridge</surname><given-names>J.V.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Papoutsaki</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Niu</surname><given-names>B.</given-names></string-name>, <string-name><surname>McLellan</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes</article-title>. <source>Nat. Genet.</source><year>2015</year>; <volume>47</volume>:<fpage>106</fpage>–<lpage>114</lpage>.<pub-id pub-id-type="pmid">25501392</pub-id></mixed-citation>
    </ref>
    <ref id="B64">
      <label>64.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Drake</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Paull</surname><given-names>E.O.</given-names></string-name>, <string-name><surname>Graham</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Titz</surname><given-names>B.</given-names></string-name>, <string-name><surname>Stoyanova</surname><given-names>T.</given-names></string-name>, <string-name><surname>Faltermeier</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Uzunangelov</surname><given-names>V.</given-names></string-name>, <string-name><surname>Carlin</surname><given-names>D.E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Phosphoproteome integration reveals patient-specific networks in prostate cancer</article-title>. <source>Cell</source>. <year>2016</year>; <volume>166</volume>:<fpage>1041</fpage>–<lpage>1054</lpage>.<pub-id pub-id-type="pmid">27499020</pub-id></mixed-citation>
    </ref>
    <ref id="B65">
      <label>65.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Snider</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kotlyar</surname><given-names>M.</given-names></string-name>, <string-name><surname>Saraon</surname><given-names>P.</given-names></string-name>, <string-name><surname>Yao</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Jurisica</surname><given-names>I.</given-names></string-name>, <string-name><surname>Stagljar</surname><given-names>I.</given-names></string-name></person-group><article-title>Fundamentals of protein interaction network mapping</article-title>. <source>Mol. Syst. Biol.</source><year>2015</year>; <volume>11</volume>:<fpage>848</fpage>.<pub-id pub-id-type="pmid">26681426</pub-id></mixed-citation>
    </ref>
    <ref id="B66">
      <label>66.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaefer</surname><given-names>M.H.</given-names></string-name>, <string-name><surname>Serrano</surname><given-names>L.</given-names></string-name>, <string-name><surname>Andrade-Navarro</surname><given-names>M.A.</given-names></string-name></person-group><article-title>Correcting for the study bias associated with protein–protein interaction measurements reveals differences between protein degree distributions from different cancer types</article-title>. <source>Front. Genet.</source><year>2015</year>; <volume>6</volume>:<fpage>260</fpage>.<pub-id pub-id-type="pmid">26300911</pub-id></mixed-citation>
    </ref>
    <ref id="B67">
      <label>67.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barel</surname><given-names>G.</given-names></string-name>, <string-name><surname>Herwig</surname><given-names>R.</given-names></string-name></person-group><article-title>NetCore: a network propagation approach using node coreness</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>e98</fpage>.<pub-id pub-id-type="pmid">32735660</pub-id></mixed-citation>
    </ref>
    <ref id="B68">
      <label>68.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lü</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>T.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>QM.</given-names></string-name>, <string-name><surname>Stanley</surname><given-names>H.E.</given-names></string-name></person-group><article-title>The <italic toggle="yes">H</italic>-index of a network node and its relation to degree and coreness</article-title>. <source>Nat. Commun.</source><year>2016</year>; <volume>7</volume>:<fpage>10168</fpage>.<pub-id pub-id-type="pmid">26754161</pub-id></mixed-citation>
    </ref>
    <ref id="B69">
      <label>69.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Repana</surname><given-names>D.</given-names></string-name>, <string-name><surname>Nulsen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dressler</surname><given-names>L.</given-names></string-name>, <string-name><surname>Bortolomeazzi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Venkata</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Tourna</surname><given-names>A.</given-names></string-name>, <string-name><surname>Yakovleva</surname><given-names>A.</given-names></string-name>, <string-name><surname>Palmieri</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ciccarelli</surname><given-names>F.D.</given-names></string-name></person-group><article-title>The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens</article-title>. <source>Genome Biol.</source><year>2019</year>; <volume>20</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">30606230</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
